Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic
Influenza remains one of the most common respiratory viral diseases with a high risk of complications. In the context of the COVID-19 pandemic, there is a possibility of simultaneous circulation of two viruses, which makes it necessary to conduct a differential diagnosis. Influenza and COVID-19 have...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2021-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/6556 |
| _version_ | 1797841876350402560 |
|---|---|
| author | N. V. Orlova V. V. Lomaychikov |
| author_facet | N. V. Orlova V. V. Lomaychikov |
| author_sort | N. V. Orlova |
| collection | DOAJ |
| description | Influenza remains one of the most common respiratory viral diseases with a high risk of complications. In the context of the COVID-19 pandemic, there is a possibility of simultaneous circulation of two viruses, which makes it necessary to conduct a differential diagnosis. Influenza and COVID-19 have common pathways of transmission of the pathogen and similar symptoms, so the optimal differential diagnosis is the use of test systems for both viruses. Against the background of influenza and COVID-19, complications from various organs and systems can develop. The article describes in detail the complications of influenza from the cardiovascular system. After infection with the flu virus, there is a 6-to 10-fold increase in the risk of acute myocardial infarction and a 3 - to 8-fold increase in the risk of stroke. COVID-19 is associated with arterial hypertension, diabetes mellitus, cardiac arrhythmias, myocarditis, high risk of acute myocardial infarction, and heart failure. The article presents the data of our own research, indicating that the transferred COVID-19 disease increases the risk of acute coronary syndrome, regardless of the presence of risk factors for cardiovascular events. Prevention of the development of influenza complications is the early administration of etiotropic antiviral therapy. Numerous studies confirm the effectiveness of the neuraminidase inhibitor oseltamivir in the treatment of influenza. The use of oseltamivir reduces the severity of clinical manifestations, reduces the duration of the disease, reduces the risk of complications and death. The most effective measure to prevent influenza and COVID-19 is specific immunization. In some cases, chemoprophylaxis can be used. The article discusses studies on the effectiveness of influenza chemoprophylaxis with the use of neuraminidase inhibitors. |
| first_indexed | 2024-04-09T16:39:42Z |
| format | Article |
| id | doaj.art-fe081b0470c745ddac5d252ff8300ac6 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:39:42Z |
| publishDate | 2021-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-fe081b0470c745ddac5d252ff8300ac62023-04-23T06:56:47ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-12-01018869310.21518/2079-701X-2021-18-86-935919Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemicN. V. Orlova0V. V. Lomaychikov1Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityInfluenza remains one of the most common respiratory viral diseases with a high risk of complications. In the context of the COVID-19 pandemic, there is a possibility of simultaneous circulation of two viruses, which makes it necessary to conduct a differential diagnosis. Influenza and COVID-19 have common pathways of transmission of the pathogen and similar symptoms, so the optimal differential diagnosis is the use of test systems for both viruses. Against the background of influenza and COVID-19, complications from various organs and systems can develop. The article describes in detail the complications of influenza from the cardiovascular system. After infection with the flu virus, there is a 6-to 10-fold increase in the risk of acute myocardial infarction and a 3 - to 8-fold increase in the risk of stroke. COVID-19 is associated with arterial hypertension, diabetes mellitus, cardiac arrhythmias, myocarditis, high risk of acute myocardial infarction, and heart failure. The article presents the data of our own research, indicating that the transferred COVID-19 disease increases the risk of acute coronary syndrome, regardless of the presence of risk factors for cardiovascular events. Prevention of the development of influenza complications is the early administration of etiotropic antiviral therapy. Numerous studies confirm the effectiveness of the neuraminidase inhibitor oseltamivir in the treatment of influenza. The use of oseltamivir reduces the severity of clinical manifestations, reduces the duration of the disease, reduces the risk of complications and death. The most effective measure to prevent influenza and COVID-19 is specific immunization. In some cases, chemoprophylaxis can be used. The article discusses studies on the effectiveness of influenza chemoprophylaxis with the use of neuraminidase inhibitors.https://www.med-sovet.pro/jour/article/view/6556influenzacovid-19cardiovascular complicationsrisk of acute coronary syndrometreatmentpreventionneuraminidase inhibitors |
| spellingShingle | N. V. Orlova V. V. Lomaychikov Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic Медицинский совет influenza covid-19 cardiovascular complications risk of acute coronary syndrome treatment prevention neuraminidase inhibitors |
| title | Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
| title_full | Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
| title_fullStr | Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
| title_full_unstemmed | Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
| title_short | Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
| title_sort | role of etiotropic therapy in the treatment and prevention of influenza complications amidst the covid 19 pandemic |
| topic | influenza covid-19 cardiovascular complications risk of acute coronary syndrome treatment prevention neuraminidase inhibitors |
| url | https://www.med-sovet.pro/jour/article/view/6556 |
| work_keys_str_mv | AT nvorlova roleofetiotropictherapyinthetreatmentandpreventionofinfluenzacomplicationsamidstthecovid19pandemic AT vvlomaychikov roleofetiotropictherapyinthetreatmentandpreventionofinfluenzacomplicationsamidstthecovid19pandemic |